NCT03132337View on ClinicalTrials.gov

Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

January 14, 2021

Study Completion Date

January 14, 2021

Conditions
Sinusoidal Obstruction Syndrome
Interventions
OTHER

Serial Blood Draws

Day 0 and Day 3 blood draw for SOS biomarkers. If subject develops SOS blood draw prior to dose of Defibrotide, Day 14 after Defibrotide and Day 21 after Defibrotide.

Trial Locations (4)

20010

Children's National Medical Center, Washington D.C.

46202

Indiana University, Indianapolis

48109

University of Michigan, Ann Arbor

77030

Baylor College of Medicine, Houston

All Listed Sponsors
lead

Indiana University

OTHER

NCT03132337 - Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study | Biotech Hunter | Biotech Hunter